The Journal of Hip Surgery 2022; 06(01): 008-014
DOI: 10.1055/s-0041-1739456
Original Article

Postoperative Doxycycline Did Not Improve Early Postoperative Outcomes in Hip Arthroscopy Patients: A Retrospective Cohort Study

Zeeshan M. Akhtar
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
,
Emily R. Hunt
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
,
Brooks N. Platt
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
,
Alex L. Turner
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
,
Cale A. Jacobs
2   Department of Orthopaedic Surgery & Sports Medicine, University of Kentucky Medical Center, Lexington, Kentucky
,
Austin V. Stone
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
,
Stephen T. Duncan
1   Department of Orthopaedics, University of Kentucky, Lexington, Kentucky
› Author Affiliations

Abstract

Doxycycline has been shown to reduce fibroblast activity in the treatment of multiple pathologies, and was utilized as part of the postoperative medication protocol to help prevent adhesions from developing after hip arthroscopy. The purpose of this study was to compare early postoperative pain outcomes between consecutive case series of femoroacetabular impingement syndrome (FAIS) patients treated with or without a 7-day postoperative course of doxycycline following hip arthroscopy. We hypothesized that the doxycycline-treated group would have superior patient-reported outcomes at 6 weeks, and the effect would be more pronounced for patients with low preoperative mental health scores.

Our institutional review board–approved prospective outcomes registry was queried for patients who had undergone arthroscopic femoral osteochondroplasty and/or labral repair or reconstruction secondary to FAIS performed by a single, fellowship-trained surgeon. A 7-day postoperative course of doxycycline was initiated in 2018. Six-week postoperative Hip Disability and Osteoarthritis Outcome Score (HOOS) global (HOOSglobal) and International Hip Outcome Tool (iHOT) scores were compared between the consecutive series treated with versus without doxycycline. Additional subgroup analysis was performed on patients with low preoperative Veterans RAND 12-Item Health Survey (VR-12) mental component scores to determine possible additional benefit of postoperative doxycycline in this group.

A total of 134 patients (98 female, 36 male, age = 36.2 ± 13.4 years, body mass index [BMI] = 27.2 ± 5 kg/m2) were identified between 2013 and 2020. There were no differences between the control (n = 84) and doxycycline group (n = 50) in age, sex, or BMI. Postoperative HOOSglobal scores (control = 58.5 ± 13.1, doxycycline = 58.7 ± 14.7, p = 0.96) and iHOT scores (control = 54.4 ± 22.2, doxycycline = 52.3 ± 24.8, p = 0.61) did not differ between groups. The subset of 83 patients with low preoperative mental scores showed no differences in HOOSglobal (control = 51.6 ± 13.3, doxycycline = 57.3 ± 7.4, p = 0.12) or iHOT scores (control = 45.5 ± 20.3, doxycycline = 53.6 ± 23.1, p = 0.250).

Our results do not support the hypothesis that postoperative doxycycline leads to significant improvement in early postoperative pain scores or functional outcomes in patients undergoing hip arthroscopy for FAIS.

Data Availability

IRB protocol# 47170, approved August 19, 2020.




Publication History

Received: 24 April 2021

Accepted: 06 October 2021

Article published online:
18 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Pun S, Kumar D, Lane NE. Femoroacetabular impingement. Arthritis Rheumatol 2015; 67 (01) 17-27
  • 2 Matsuda DK, Carlisle JC, Arthurs SC, Wierks CH, Philippon MJ. Comparative systematic review of the open dislocation, mini-open, and arthroscopic surgeries for femoroacetabular impingement. Arthroscopy 2011; 27 (02) 252-269
  • 3 Philippon MJ, Schenker ML, Briggs KK, Kuppersmith DA, Maxwell RB, Stubbs AJ. Revision hip arthroscopy. Am J Sports Med 2007; 35 (11) 1918-1921
  • 4 Minkara AA, Westermann RW, Rosneck J, Lynch TS. Systematic review and meta-analysis of outcomes after hip arthroscopy in femoroacetabular impingement. Am J Sports Med 2019; 47 (02) 488-500
  • 5 Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol 2011; 17 (41) 4545-4553
  • 6 Shin JJ, McCrum CL, Mauro CS, Vyas D. Pain management after hip arthroscopy: systematic review of randomized controlled trials and cohort studies. Am J Sports Med 2018; 46 (13) 3288-3298
  • 7 Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res 2019; 7: 9
  • 8 Brandt KD, Mazzuca SA, Katz BP. et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005; 52 (07) 2015-2025
  • 9 Farhad SZ, Aminzadeh A, Mafi M, Barekatain M, Naghney M, Ghafari MR. The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. Dent Res J (Isfahan) 2013; 10 (05) 624-629
  • 10 Castro MM, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension. Pharmacol Res 2011; 64 (06) 567-572
  • 11 Sagar DR, Burston JJ, Hathway GJ. et al. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain 2011; 7: 88
  • 12 Rosenblum A, Landy DC, Perrone MA, Whyte N, Kang R. The presence of a psychiatric condition is associated with undergoing hip arthroscopy for femoroacetabular impingement: a matched case-controlled study. J Arthroplasty 2019; 34 (03) 446-449
  • 13 Stone AV, Malloy P, Beck EC. et al. Predictors of persistent postoperative pain at minimum 2 years after arthroscopic treatment of femoroacetabular impingement. Am J Sports Med 2019; 47 (03) 552-559
  • 14 Jacobs CA, Burnham JM, Jochimsen KN, Molina IV D, Hamilton DA, Duncan ST. Preoperative symptoms in femoroacetabular impingement patients are more related to mental health scores than the severity of labral tear or magnitude of bony deformity. J Arthroplasty 2017; 32 (12) 3603-3606
  • 15 Selim AJ, Rogers W, Fleishman JA. et al. Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res 2009; 18 (01) 43-52
  • 16 Clohisy JC, Carlisle JC, Beaulé PE. et al. A systematic approach to the plain radiographic evaluation of the young adult hip. J Bone Joint Surg Am 2008; 90 (Suppl. 04) 47-66
  • 17 Mittal A, Bomar JD, Jeffords ME, Huang MT, Wenger DR, Upasani VV. Defining the lateral edge of the femoroacetabular articulation: correlation analysis between radiographs and computed tomography. J Child Orthop 2016; 10 (05) 365-370
  • 18 Jacobs CA, Peabody MR, Duncan ST. et al; ANCHOR Group. Development of the HOOSglobal to assess patient-reported outcomes in patients undergoing hip preservation procedures. Am J Sports Med 2018; 46 (04) 940-946
  • 19 R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2010. . Available at: http://www.R-project.org
  • 20 Bastos LF, de Oliveira AC, Watkins LR, Moraes MF, Coelho MM. Tetracyclines and pain. Naunyn Schmiedebergs Arch Pharmacol 2012; 385 (03) 225-241
  • 21 Tilley BC, Alarcón GS, Heyse SP. et al; MIRA Trial Group. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995; 122 (02) 81-89
  • 22 O'Dell JR, Blakely KW, Mallek JA. et al. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 2001; 44 (10) 2235-2241
  • 23 O'Dell JR, Haire CE, Palmer W. et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997; 40 (05) 842-848
  • 24 O'Dell JR, Paulsen G, Haire CE. et al. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum 1999; 42 (08) 1691-1695
  • 25 Stone M, Fortin PR, Pacheco-Tena C, Inman RD. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol 2003; 30 (10) 2112-2122
  • 26 Schwarze M, Häuser W, Schmutzer G, Brähler E, Beckmann NA, Schiltenwolf M. Obesity, depression and hip pain. Musculoskelet Care 2019; 17 (01) 126-132
  • 27 Ghoneim MM, O'Hara MW. Depression and postoperative complications: an overview. BMC Surg 2016; 16: 5
  • 28 Berk M, Williams LJ, Jacka FN. et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med 2013; 11: 200
  • 29 Dean OM, Data-Franco J, Giorlando F, Berk M. Minocycline: therapeutic potential in psychiatry. CNS Drugs 2012; 26 (05) 391-401
  • 30 Holmes SE, Hinz R, Conen S. et al. Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 2018; 83 (01) 61-69
  • 31 Cai DB, Zheng W, Zhang QE. et al. Minocycline for depressive symptoms: a meta-analysis of randomized, double-blinded, placebo-controlled trials. Psychiatr Q 2020; 91 (02) 451-461
  • 32 Shultz RB, Zhong Y. Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen Res 2017; 12 (05) 702-713
  • 33 Mehta N, Chamberlin P, Marx RG. et al. Defining the learning curve for hip arthroscopy: a threshold analysis of the volume-outcomes relationship. Am J Sports Med 2018; 46 (06) 1284-1293